Role of the National Cholesterol Education Program Adult treatment panel III guidelines in managing dyslipidemia.

Research output: Contribution to journalArticlepeer-review

16 Scopus citations


Using recently updated guidelines to evaluate and manage lipid disorders is discussed. Coronary heart disease (CHD) is a costly chronic condition associated with significant morbidity and mortality. Epidemiologic data further indicate that dyslipidemia and associated conditions, which may lead to CHD, are grossly undertreated. In 2001, the third National Cholesterol Education Program (NCEP) Adult Treatment Panel (ATP III) released updated guidelines for the evaluation and treatment of lipid disorders. Significant changes to the updated guidelines include designation of a CHD risk equivalent category identifying patients who require aggressive management, recommendation of Framingham-based CHD risk assessment in patients with multiple risk factors, revised target levels for several of the lipids and lipoproteins, and criteria for the identification of patients with the metabolic syndrome. Low-density lipoprotein cholesterol (LDL-C) continues to be the primary target of therapy. In addition, non-high-density lipoprotein cholesterol (HDL-C) is now defined as a secondary treatment target in patients with hypertriglyceridemia. Increased emphasis is placed on the metabolic syndrome, low HDL-C levels, and the presence of multiple and emerging risk factors in guiding the intensity of therapy. The NCEP ATP III guidelines acknowledge challenges in implementing and maintaining patient adherence to both lifestyle changes and pharmacotherapy regimens and provide strategies for increasing treatment success. Implementation of these new guidelines will likely enhance identification, management, and treatment success rates among patients at risk for CHD in the United States.

Original languageEnglish (US)
Pages (from-to)S3-8; quiz S25
JournalAmerican journal of health-system pharmacy : AJHP : official journal of the American Society of Health-System Pharmacists
Issue number13 Suppl 2
StatePublished - Jul 1 2003
Externally publishedYes

ASJC Scopus subject areas

  • Pharmacology
  • Health Policy


Dive into the research topics of 'Role of the National Cholesterol Education Program Adult treatment panel III guidelines in managing dyslipidemia.'. Together they form a unique fingerprint.

Cite this